COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,788 Articles (22,523 medRxiv, 8,265 bioRxiv)

Most recent first Previous |  Page 978: Articles 9771-9780  | Next

COVIDFast: A high-throughput and RNA extraction-free method for SARS-CoV-2 detection in swab (SwabFAST) or saliva (SalivaFAST)
Qiu, Y., Lu, L., Halven, A., Terrio, R., Yuldelson, S., Dougal, N., Galbo, F., Lu, A., Gao, D., Blomquist, B., Zevallos, J., Harry, B., Yao, X., Lu, S.-L.
10.1101/2021.12.29.21268527 — Posted: 2022-01-01
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancies and COVID-19: a longitudinal cohort and propensity score analysis
Hueso, t., Godron, A.-S., Lanoy, E., Pakanowski, J., Levi, L. I., Gras, E., Surgers, L., Guemriche, A., Meynard, J.-M., Pirenne, F., Idri, S., Tiberghien, P., Morel, P., Besson, C., Dulery, R., Lamure, S., Hermine, O., Gagneux-Brunon, A., Freymond, N., Grabar, S., Lacombe, K.
10.1101/2021.12.29.21268525 — Posted: 2022-01-01
Estimating the direct Disability-Adjusted Life Years (DALYs) associated with SARS-CoV-2 (COVID-19) in the Republic of Ireland: The first full year
Moran, D. P., Montero Pires, S., Wyper, G. M., Devleesschauwer, B., Cuschieri, S., Kabir, Z.
10.1101/2021.12.29.21268120 — Posted: 2022-01-01
Transition of antibody titers after the SARS-CoV-2 mRNA vaccine in Japanese healthcare workers
Kitabatake, M., Ouji-Sageshima, N., Sonobe, S., Furukawa, R., Konda, M., Hara, A., Aoki, H., Suzuki, Y., Imakita, N., Nakano, A., Fujita, Y., Shichino, S., Nakano, R., Ueha, S., Kasahara, K., Muro, S., Yano, H., Matsushima, K., Ito, T.
10.1101/2021.12.28.21268435 — Posted: 2021-12-31
Long-lasting cellular immunity to SARS-CoV-2 following infection or vaccination and implications for booster strategies
Mazzoni, A., Vanni, A., Spinicci, M., Lamacchia, G., Kiros, S. T., Rocca, A., Capone, M., Di Lauria, N., Salvati, L., Carnasciali, A., Mantengoli, E., Farahvachi, P., Zammarchi, L., Lagi, F., Colao, M. G., Liotta, F., Cosmi, L., Maggi, L., Bartoloni, A., Rossolini, G. M., Annunziato, F.
10.1101/2021.12.29.21268469 — Posted: 2021-12-31
Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test
Roessler, J., Pich, D., Albanese, M., Wratil, P. R., Kraehling, V., Hellmuth, J. C., Scherer, C., Bergwelt-Baildon, M. v., Becker, S., Keppler, O. T., Brisson, A., Zeidler, R., Hammerschmidt, W.
10.1101/2021.12.29.21268487 — Posted: 2021-12-31
Immunomodulation by intravenous omega-3 fatty acid treatment in older subjects hospitalized for COVID-19: a single-blind randomized controlled trial
Arnardottir, H., Pawelzik, S.-C., Sarajlic, P., Quaranta, A., Kolmert, J., Religa, D., Wheelock, C. E., Back, M.
10.1101/2021.12.27.21268264 — Posted: 2021-12-31
COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies
Di Fusco, M., Lin, J., Vaghela, S., Lingohr-Smith, M., Nguyen, J. L., Scassellati Sforzolini, T., Judy, J., Cane, A., Moran, M. M.
10.1101/2021.12.29.21268511 — Posted: 2021-12-31
Neutralization of ancestral SARS-CoV-2 and variants Alpha, Beta, Gamma, Delta, Zeta and Omicron by mRNA vaccination and infection-derived immunity through homologous and heterologous variants
Bekliz, M., Adea, K., Vetter, P., Eberhardt, C. S., Hosszu-Fellous, K., Vu, D.-L., Puhach, O., Essaidi-Laziosi, M., Waldvogel-Abramowski, S., Stephan, C., L'Huillier, A., Siegrist, C.-A., Didierlaurent, A. M., Kaiser, L. M., Meyer, B., Eckerle, I.
10.1101/2021.12.28.21268491 — Posted: 2021-12-31
A cohort study of the effect of SARS-CoV-2 point of care rapid RT-PCR at the Emergency Department on targeted admission
Mortazavi, S. E., Inghammar, M., Christansen, C., Pesola, A.-K., Stenkilsson, M., Paulsson, M.
10.1101/2021.12.29.21268501 — Posted: 2021-12-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).